New CEO to lead Clanwilliam Health

Clanwilliam Health is pleased to announce Mike Weiss has been appointed as CEO effective from 1 October 2020.

Mr Weiss previously served as Deputy CEO and Chief Commercial Officer of the business.

He takes over from Michelle Creighton who decided to step down after more than 10 years in senior leadership roles in the business.

“My sincere thanks go to Michelle for her many years of exemplary service; she has left the business well placed to continue to support healthcare providers, funders and patients in New Zealand, Australia, and Hong Kong,” Mr Weiss says.

“As Deputy CEO I’ve worked closely with Michelle and I, along with our leadership team, will ensure that this transition is smooth for our customers.”

Clanwilliam Health was created in 2019 when Auckland-based healthcare technology companies HealthLink and Konnect NET merged. Mr Weiss served as CEO of Konnect NET prior to the merger.

Mr Weiss says he is delighted to have the opportunity to lead Clanwilliam Health.

“Clanwilliam Health has a rich heritage of supporting healthcare providers, payers and patients in New Zealand and Australia through a range of products and services,” he says.

Mr Weiss says Clanwilliam Health will remain focussed on its customers, patient outcomes, provider experience and protecting sensitive information.

“There are significant growth opportunities in New Zealand and Australia. The organisations that will be successful in the next decade are those that are able to master the balance between focussing on their core value proposition and being able to collaborate with others for better patient outcomes.”


Next stage of the journey

Clanwilliam Health is part of the Ireland-headquartered Clanwilliam Group family of healthcare technology and services businesses.

Beginning in 2017, Clanwilliam Group has invested in excess of NZ $100m in the Australasian healthcare technology market. Other Clanwilliam Group businesses in the region include Toniq and MBS.

Clanwilliam Group CEO Howard Beggs says Mr Weiss will lead the next stage of Clanwilliam’s journey in New Zealand and Australia.

“Clanwilliam Health is the anchor for Clanwilliam Group’s continued growth, innovation and investment in the Australasian market. We remain committed to investing in strong and innovative healthcare technology businesses that support clinicians in delivering great care to their patients.

“I’m confident that Mike and the local leadership team will execute on Clanwilliam Group’s vision of making healthcare better for everyone”.


For media assistance, please contact:

Maggie McNaughton

Clanwilliam Health publicist

021 613198

[email protected]

Mercy Radiology’s new digital scanner

Mercy Radiology’s new digital PET-CT scanner is the latest tool available in the fight against prostate cancer.

It was unveiled last month at Mercy Radiology’s new Milford clinic on Auckland’s North Shore. In New Zealand, prostate cancer is the most common cancer in men.

Mercy Radiology has 14 branches located around the wider Auckland area, offering a full spectrum of diagnostic radiology services.

Referrals to Mercy Radiology and Mercy Breast Clinic can now be made via CareSelect.


Clarity is everything

Mercy Radiology Group’s director of strategic programmes Alexis Stewart says the new digital PET-CT scanner provides better quality images compared to analogue scanners.

“This means cancers can be detected earlier and therefore treatment can begin earlier. If cancer is caught earlier, survivorship and quality of life can be greatly improved,” Alexis says.

PSMA scanning is also used to help detect cancers.

“Radioactive isotopes find and bind to the cancerous cells making it easier to pinpoint where the cancer is and if it has spread. This accurate information can then be used to help make the right and most effective treatment choices.”

Another new tool Mercy Radiology is using in the fight against prostate cancer is Lutetium therapy.

“Lutetium locks onto cancerous cells and leaves the healthy cells alone, which means less side effects compared to other palliative treatments like chemotherapy. Again, greatly improving our patients’ quality of life,” she says.

The therapy is currently used only for prostate cancer patients receiving palliative care, however new research from Australia is strongly suggesting it may be used for all prostate cancer patients in the future.


Early detection key: All 2D mammograms replaced

Alexis says Mercy Radiology recently replaced all its 2D mammogram machines with 3D tomosynthesis machines.

“The 3D imaging picks up more cancerous cells earlier than the 2D imaging, particularly for women who have dense breast tissue. Early detection is proven to improve survivorship.”

Mercy Radiology’s one-stop clinics are also helping in the fight against cancer by providing patient streamlined services and care that eliminates the need for multiple appointments over a long period of time.

“This fast-tracks the time to diagnosis by getting earlier detection and treatment. For some of our clinics, you can have your diagnosis and an initial treatment plan in as little as 45 minutes compared to the traditional two to six week wait,” she says.


How to refer Mercy Radiology Group:

Mercy Radiology have branches in the Auckland CBD, Botany, Epsom, Milford, Orewa, Pakuranga, Red Beach, Rosedale, Silverdale, St Lukes, Takapuna, Warkworth, and Westgate.

Refer to their central Booking Team who will make an appointment at the location most convenient to your patient.

  • open the patient record
  • launch the HealthLink homepage
  • using the CareSelect search bar, type Mercy Radiology or Mercy Breast Clinic
  • click “Compose Referral”.